Literature DB >> 31196469

Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure.

Alberto Aimo, Michele Emdin, Alan S Maisel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31196469     DOI： 10.1016/j.jacc.2019.03.510

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Dilated cardiomyopathy and aldosteronoma: a causal link?

Authors:  Jiyu Zhang; Jin Yang; Yueliang Li
Journal:  ESC Heart Fail       Date:  2019-12-19

Review 2.  Recently Approved and Under Investigation Drugs for Treating Patients with Heart Failure.

Authors:  Yaniel Castro-Torres; Richard E Katholi
Journal:  Curr Cardiol Rev       Date:  2020

3.  Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences.

Authors:  Matteo Castrichini; Paolo Manca; Vincenzo Nuzzi; Giulia Barbati; Antonio De Luca; Renata Korcova; Davide Stolfo; Andrea Di Lenarda; Marco Merlo; Gianfranco Sinagra
Journal:  J Clin Med       Date:  2020-03-25       Impact factor: 4.241

4.  Usefulness of a Nurse-Led Program of Care for Management of Patients with Chronic Heart Failure.

Authors:  Jinyan You; Suping Wang; Jing Li; Yuanping Luo
Journal:  Med Sci Monit       Date:  2020-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.